Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick N Harter

Showing results (81-90 of 205) with videos related to

Pageof 21
Sort By:
Journal of the National Cancer Institute|December 8, 2015
ErbB2/HER2-Specific NK Cells for Targeted Therapy of GlioblastomaCongcong Zhang, Michael C Burger, Lukas Jennewein, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's diseaseKavi Devraj, Slobodan Poznanovic, Christoph Spahn, et al.
Cancer Research|February 1, 2018
Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in NeuroblastomaAnja Groß, Catrine Schulz, Jasmine Kolb, et al.
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Plos One|April 19, 2014
Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acidSebastian Fischer, Michael W Ronellenfitsch, Anna-Luisa Thiepold, et al.
Cancers|November 3, 2020
Non-Invasive Measurement of Drug and 2-HG Signals Using <sup>19</sup>F and <sup>1</sup>H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032Katharina J Wenger, Christian Richter, Michael C Burger, et al.
Cancers|October 23, 2020
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal CancerHans Urban, Gabriele D Maurer, Anna-Luisa Luger, et al.
Neuropathology and Applied Neurobiology|March 29, 2021
TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastomaNaita M Wirsik, Jakob Ehlers, Lisa Mäder, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Frontiers in Pharmacology|September 21, 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironmentEva Proestler, Julia Donzelli, Sheila Nevermann, et al.
Pageof 21

Showing results (81-90 of 205) with videos related to

Sort By:
Pageof 21
Journal of the National Cancer Institute|December 8, 2015
ErbB2/HER2-Specific NK Cells for Targeted Therapy of GlioblastomaCongcong Zhang, Michael C Burger, Lukas Jennewein, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 15, 2015
BACE-1 is expressed in the blood-brain barrier endothelium and is upregulated in a murine model of Alzheimer's diseaseKavi Devraj, Slobodan Poznanovic, Christoph Spahn, et al.
Cancer Research|February 1, 2018
Tumorigenic and Antiproliferative Properties of the TALE-Transcription Factors MEIS2D and MEIS2A in NeuroblastomaAnja Groß, Catrine Schulz, Jasmine Kolb, et al.
Oncology Letters|July 12, 2017
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustineKatharina J Wenger, Marlies Wagner, Se-Jong You, et al.
Plos One|April 19, 2014
Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acidSebastian Fischer, Michael W Ronellenfitsch, Anna-Luisa Thiepold, et al.
Cancers|November 3, 2020
Non-Invasive Measurement of Drug and 2-HG Signals Using <sup>19</sup>F and <sup>1</sup>H MR Spectroscopy in Brain Tumors Treated with the Mutant IDH1 Inhibitor BAY1436032Katharina J Wenger, Christian Richter, Michael C Burger, et al.
Cancers|October 23, 2020
Cetuximab-Mediated Protection from Hypoxia- Induced Cell Death: Implications for Therapy Sequence in Colorectal CancerHans Urban, Gabriele D Maurer, Anna-Luisa Luger, et al.
Neuropathology and Applied Neurobiology|March 29, 2021
TGF-β activates pericytes via induction of the epithelial-to-mesenchymal transition protein SLUG in glioblastomaNaita M Wirsik, Jakob Ehlers, Lisa Mäder, et al.
Neuro-Oncology Advances|November 29, 2023
Gliomatosis cerebri (GC) growth pattern: A single-center analysis of clinical, histological, and molecular characteristics of GC and non-GC glioblastomaIris Divé, Katharina J Weber, Tabea I Hartung, et al.
Frontiers in Pharmacology|September 21, 2023
The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironmentEva Proestler, Julia Donzelli, Sheila Nevermann, et al.
Pageof 21